Aquestive Therapeutics Inc (AQST)
R&D Expenses
$3.96M
Quarterly · Period ending: · USD
AQST R&D Expenses
Latest reported$3.96Mperiod ending
Latest reported$3.96Mperiod ending
AQST Quarterly R&D Expenses ($5.34M → $3.96M)
Quarterly R&D Expenses
High-resolution chart · PNG
AQST r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 3,962,000 | |
| 4,204,000 | |
| 3,196,000 | |
| 4,530,000 | |
| 4,105,000 | |
| 5,361,000 | |
| 4,917,000 | |
| 5,269,000 | |
| 4,162,000 | |
| 5,932,000 | |
| 2,888,000 | |
| 3,196,000 | |
| 3,473,000 | |
| 3,547,000 | |
| 4,278,000 | |
| 3,232,000 | |
| 5,198,000 | |
| 4,773,000 | |
| 4,400,000 | |
| 4,726,000 | |
| 4,262,000 | |
| 3,659,000 | |
| 4,425,000 | |
| 7,260,000 | |
| 3,847,000 | |
| 4,354,000 | |
| 3,057,000 | |
| 5,063,000 | |
| 8,151,000 | |
| 4,303,000 | |
| 5,683,000 | |
| 4,534,000 | |
| 7,994,000 | |
| 4,901,000 | |
| 6,271,000 | |
| 5,684,000 | |
| 4,837,000 | |
| 5,343,000 |